Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Run silent, run deep

Run silent, run deep

diaDexus LLC was announced with great fanfare in 1997 by founding companies SmithKline Beecham and Incyte Pharmaceuticals Inc., which promised that the new company would bring an unprecedented intensity to the development of molecular diagnostics and, ultimately, to pharmacogenomics. For the

Read the full 458 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers